# US 2021/0077418 A1 · Methods for improving the microbiome and its systemic effect

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0077418 A1
- Document ID: US20210077418A1
- Status: Published application
- Kind: A1
- Application number: 17/050,127
- Filed: 2019-04-26
- Published: 2021-03-18
- Earliest claimed: 2018-04-27
- Assignees: IP Science Limited
- Applicants: IP Science Limited
- Inventors: Ivan PETYAEV
- Web page: https://patentgrep.com/patent/US20210077418A1

## CPC

- A23L 33/155: Vitamins A or D
- A61K 31/015: carbocyclic
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A61K 31/01: Hydrocarbons
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/07: Retinol compounds, e.g. vitamin A (retinoic acids A61K31/203)
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/336: having three-membered rings, e.g. oxirane, fumagillin
- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- A61K 35/745: Bifidobacteria
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A23V 2250/213: Lycopene
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

We describe that carotenoids provide a prebiotic effect and can be used to improve the health of the gut microbiome.

## Claims

### Claim 1

A use of a carotenoid compound in promoting growth or increasing the abundance of a Bifidobacterium in the gastro-intestinal tract, mouth or urogenital system of a subject.

### Claim 2 (depends on 1)

The use according to claim 1 wherein the carotenoid compound is selected from lycopene, lutein, zeaxanthin, meso-zeaxanthin, astaxanthin, α- or β- or other carotenes, cryptoxanthins, flavoxanthin, neoxanthin or another tetraterpenoid.

### Claim 3 (depends on 2)

The use according to claim 2 wherein the carotenoid compound is a lycopene.

### Claim 4

The use according to a preceding claim wherein the Bifidobacterium is selected from Bifidobacterium adolescentis, Bifidobacterium catenulatum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium animalis, Bifidobacterium longum, Bifidobacterium lactis, Bifidobacterium pseudocatenulatum, Bifidobacterium longum, Bifidobacterium angulatum, Bifidobacterium kashiwanohense, Bifidobacterium dentum or Bifidobacterium stercoris.

### Claim 5

The use according to a preceding claim wherein the subject is a human, or a terrestrial or a sea animal.

### Claim 6

A method for promoting growth or increasing the abundance of a Bifidobacterium in the gastro-intestinal tract, or other organs which could be populated with this bacteria, of a subject comprising administration of a carotenoid.

### Claim 7

A method for the prophylaxis or treatment of an inflammation related gastro-intestinal, mouth or urogenital system, condition in a subject comprising administration of a carotenoid.

### Claim 8

A method for the prophylaxis or treatment of a body condition which can be dependent on or associated with the status of the gastro-intestinal mouth or urogenital system health in a subject comprising administration of a carotenoid.

### Claim 9 (depends on 6, 8)

The method according to claim 6 or 8 wherein the carotenoid compound is selected from lycopene, lutein, zeaxanthin, meso-zeaxanthin, astaxanthin, α- or β- or other carotenes, cryptoxanthins, flavoxanthin, neoxanthin or another tetraterpenoid.

### Claim 10 (depends on 9)

The method according to claim 9 wherein the carotenoid compound is a lycopene.

### Claim 11 (depends on 6, 7, 8, 9, 10)

The method according to any of claims 6 to 10 wherein the Bifidobacterium is selected from Bifidobacterium adolescentis, Bifidobacterium catenulatum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium animalis, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus bifidus, Bifidobacterium pseudocatenulatum, Bifidobacterium longum, Bifidobacterium angulatum, Bifidobacterium kashiwanohense, Bifidobacterium dentum or Bifidobacterium stercoris.

### Claim 12 (depends on 6, 7, 8, 9, 10, 11)

The method according to any of claims 6 to 11 wherein the condition is selected from gastrointestinal diseases such as inflammatory bowel syndrome, constipation, diarrhoea, colitis, Crohn's disease, colon cancer, functional bowel disorder, irritable bowel syndrome, or mouth pathologies, or urogenital system pathologies, or not-gastrointestinal, or mouth, or urogenital connected to the health of gut, or mouth, or urogenital system health, such as metabolic syndrome, obesity, cardio- and cerebrovascular diseases, cancer, neurodegenerative, bone, mental and skin pathologies.

### Claim 13 (depends on 1, 2, 3, 4, 5)

The use according to claims 1 to 5 where carotenoid compound is an ingredient of a medical or functional food, or functional beverage, or be as a nutraceutical or pharmaceutical product.

### Claim 14

A composition comprising a carotenoid and one or more probiotic bacteria.

### Claim 15 (depends on 14)

The composition according to claim 14 wherein the carotenoid compound is selected from lycopene, lutein, zeaxanthin, meso-zeaxanthin, astaxanthin, α- or β- or other carotenes, cryptoxanthins, flavoxanthin, neoxanthin or another tetraterpenoid.

### Claim 16 (depends on 15)

The composition according to claim 15 wherein the carotenoid compound is a lycopene.

### Claim 17 (depends on 14, 15, 16)

The composition according to claims 14 to 16 which can be an ingredient of a medical or functional food, or functional beverage, or be as a nutraceutical or pharmaceutical product.

### Claim 18 (depends on 14, 15, 16, 17)

The composition according to any of claims 14 to 17 wherein the one or more probiotic bacteria are selected from Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus paracasei, Leuconostoc mesenteroides, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Acidophilus, Acidophilus Bifidus, Acidophilus Lactobacillus, L. Acidophilus, L. Amylovorus, L. Brevis, L. Casei Immunitas, L. Crispatus, L. Delbrueckii, L. Fermentum, L. Gallinarum, L. Helveticus, L. Johnsonii, L. Johnsonii LC-1, L. Lactis, L. Plantarum, L. Reuteri, L. Rhamnosus, L. Salivarius, L. Sporogenes, Lacto Bacillus, Lactobacille, Lactobacilli, Lactobacilli Bulgaricus, Lactobacilli Plantarum, Lactobacilli Rhamnosus, Lactobacilli Salivarium, Lactobacillus acidophilus, Lactobacillus amylovorus, Lactobacillus brevis, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus casei sp. rhamnosus, Lactobacillus crispatus, Lactobacillus delbrueckii, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus fermentum, Lactobacillus gallinarum, Lactobacillus Gasseri, Lactobacillus GG, Lactobacillus Helveticus, Lactobacillus Johnsonii, Lactobacillus Lactis, Lactobacillus reuteri, Lactobacillus Rhamnosus GG, Lactobacillus rhamnosus, Lactobacillus sakei, Lactobacillus sporogenes, Lactobacilo, Lactospores, LC-1, Probiotics, Probiotiques, Pediococcus pentosaceus, Streptococcus thermophilus, Bacillus subtilis, Bacillus coagulans, Enteroccous faecium, Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium longum, and Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium animalis or Bifidobacterium longum.
